BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 35628134)

  • 1. Age-Related DNA Methylation in Normal Kidney Tissue Identifies Epigenetic Cancer Risk Susceptibility Loci in the ANKRD34B and ZIC1 Genes.
    Serth J; Peters I; Hill B; Hübscher T; Hennenlotter J; Klintschar M; Kuczyk MA
    Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628134
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Age-, tumor-, and metastatic tissue-associated DNA hypermethylation of a T-box brain 1 locus in human kidney tissue.
    Serth J; Peters I; Dubrowinskaja N; Reese C; Albrecht K; Klintschar M; Lafos M; Grote A; Becker A; Hennenlotter J; Stenzl A; Tezval H; Kuczyk MA
    Clin Epigenetics; 2020 Feb; 12(1):33. PubMed ID: 32070431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.
    Atschekzei F; Hennenlotter J; Jänisch S; Großhennig A; Tränkenschuh W; Waalkes S; Peters I; Dörk T; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
    Epigenetics; 2012 May; 7(5):447-57. PubMed ID: 22419128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA methylation of neural EGFL like 1 (NELL1) is associated with advanced disease and the metastatic state of renal cell cancer patients.
    Peters I; Dubrowinskaja N; Hennenlotter J; Antonopoulos WI; Von Klot CAJ; Tezval H; Stenzl A; Kuczyk MA; Serth J
    Oncol Rep; 2018 Dec; 40(6):3861-3868. PubMed ID: 30272321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic and diagnostic relevance of hypermethylated in cancer 1 (HIC1) CpG island methylation in renal cell carcinoma.
    Eggers H; Steffens S; Grosshennig A; Becker JU; Hennenlotter J; Stenzl A; Merseburger AS; Kuczyk MA; Serth J
    Int J Oncol; 2012 May; 40(5):1650-8. PubMed ID: 22327210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a Novel Renal Metastasis Associated CpG-Based DNA Methylation Signature (RMAMS).
    Serth J; Peters I; Katzendorn O; Dang TN; Moog J; Balli Z; Reese C; Hennenlotter J; Grote A; Lafos M; Tezval H; Kuczyk MA
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GATA5 CpG island methylation in renal cell cancer: a potential biomarker for metastasis and disease progression.
    Peters I; Eggers H; Atschekzei F; Hennenlotter J; Waalkes S; Tränkenschuh W; Grosshennig A; Merseburger AS; Stenzl A; Kuczyk MA; Serth J
    BJU Int; 2012 Jul; 110(2 Pt 2):E144-52. PubMed ID: 22289415
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A genome-wide screen for promoter methylation in lung cancer identifies novel methylation markers for multiple malignancies.
    Shames DS; Girard L; Gao B; Sato M; Lewis CM; Shivapurkar N; Jiang A; Perou CM; Kim YH; Pollack JR; Fong KM; Lam CL; Wong M; Shyr Y; Nanda R; Olopade OI; Gerald W; Euhus DM; Shay JW; Gazdar AF; Minna JD
    PLoS Med; 2006 Dec; 3(12):e486. PubMed ID: 17194187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polycomb group genes are targets of aberrant DNA methylation in renal cell carcinoma.
    Avissar-Whiting M; Koestler DC; Houseman EA; Christensen BC; Kelsey KT; Marsit CJ
    Epigenetics; 2011 Jun; 6(6):703-9. PubMed ID: 21610323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA methylation of tumor associated calcium signal transducer 2 (TACSTD2) loci shows association with clinically aggressive renal cell cancers.
    Katzendorn O; Peters I; Dubrowinskaja N; Tezval H; Tabrizi PF; von Klot CA; Hennenlotter J; Lafos M; Kuczyk MA; Serth J
    BMC Cancer; 2021 Apr; 21(1):444. PubMed ID: 33882870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context.
    Christensen BC; Houseman EA; Marsit CJ; Zheng S; Wrensch MR; Wiemels JL; Nelson HH; Karagas MR; Padbury JF; Bueno R; Sugarbaker DJ; Yeh RF; Wiencke JK; Kelsey KT
    PLoS Genet; 2009 Aug; 5(8):e1000602. PubMed ID: 19680444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multi-omics analysis of tumor angiogenesis characteristics and potential epigenetic regulation mechanisms in renal clear cell carcinoma.
    Zheng W; Zhang S; Guo H; Chen X; Huang Z; Jiang S; Li M
    Cell Commun Signal; 2021 Mar; 19(1):39. PubMed ID: 33761933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome-wide methylation profiling identified novel differentially hypermethylated biomarker MPPED2 in colorectal cancer.
    Gu S; Lin S; Ye D; Qian S; Jiang D; Zhang X; Li Q; Yang J; Ying X; Li Z; Tang M; Wang J; Jin M; Chen K
    Clin Epigenetics; 2019 Mar; 11(1):41. PubMed ID: 30846004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer.
    Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B
    Gene; 2021 Mar; 772():145376. PubMed ID: 33359128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic screen identifies genotype-specific promoter DNA methylation and oncogenic potential of CHRNB4.
    Scherf DB; Sarkisyan N; Jacobsson H; Claus R; Bermejo JL; Peil B; Gu L; Muley T; Meister M; Dienemann H; Plass C; Risch A
    Oncogene; 2013 Jul; 32(28):3329-38. PubMed ID: 22945651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential DNA methylation with age displays both common and dynamic features across human tissues that are influenced by CpG landscape.
    Day K; Waite LL; Thalacker-Mercer A; West A; Bamman MM; Brooks JD; Myers RM; Absher D
    Genome Biol; 2013; 14(9):R102. PubMed ID: 24034465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Susceptibility of nonpromoter CpG islands to de novo methylation in normal and neoplastic cells.
    Nguyen C; Liang G; Nguyen TT; Tsao-Wei D; Groshen S; Lübbert M; Zhou JH; Benedict WF; Jones PA
    J Natl Cancer Inst; 2001 Oct; 93(19):1465-72. PubMed ID: 11584062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An effective seven-CpG-based signature to predict survival in renal clear cell carcinoma by integrating DNA methylation and gene expression.
    Xu L; He J; Cai Q; Li M; Pu X; Guo Y
    Life Sci; 2020 Feb; 243():117289. PubMed ID: 31926254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor-specific hypermethylation of epigenetic biomarkers, including SFRP1, predicts for poorer survival in patients from the TCGA Kidney Renal Clear Cell Carcinoma (KIRC) project.
    Ricketts CJ; Hill VK; Linehan WM
    PLoS One; 2014; 9(1):e85621. PubMed ID: 24454902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection and evaluation of DNA methylation markers found at SCGN and KLF14 loci to estimate human age.
    Alghanim H; Antunes J; Silva DSBS; Alho CS; Balamurugan K; McCord B
    Forensic Sci Int Genet; 2017 Nov; 31():81-88. PubMed ID: 28854399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.